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This Month in the Journal
In the last installment of “This Month in the Journal,”
I stated that Dr. Rando Allikmets wrote an editorial
highlighting “the work of both Rivera et al. (p. 800),
who find that mutations in ABCR are the major cause
of autosomal recessive cone-rod dystrophy, and Mau-
geri et al. (p. 960), who provide further evidence that
sequence variation in ABCR is associated with age-re-
lated macular degeneration.” This should have read “the
work of both Maugeri et al. (p. 960), who find that
mutations in ABCR are the major cause of autosomal
recessive cone-rod dystrophy, and Rivera et al. (p. 800),
who provide further evidence that sequence variation in
ABCR is associated with Stargardt disease.” I apologize
to both sets of authors for this error.
In this month’s issue, Villavicencio et al. (p. 1047)
have contributed a review on the Sonic hedgehog (SHH)
pathway. They outline SHH signaling through the
PATCHED receptors to the GLI family of transcription
factors. They also provide an overview of the wide range
of disorders, from holoprosencephaly to cancers, that
result from dysregulation of this crucial developmental
pathway. Next up are two invited editorials on the re-
construction of population histories. The first, by Peter
de Knijff (p. 1055), discusses some caveats for the re-
construction of human genetic histories via unique mu-
tation events and short tandem repeats on the Y chro-
mosome. The second, by Mark Seielstad (p. 1062),
discusses two articles—one by Mesa et al. (p. 1277) and
the other by Carvajal-Cormona et al. (p. 1287)—that,
in studies of the genetic histories of several South Amer-
ican populations, have found that the current population
of Antioquia (Colombia) is probably derived from an
original population that had a highly asymmetric mating
pattern between European males and native females.
Furthermore, they have found no evidence to suggest
differences in sex-specific migration rates during the ev-
olution of native Colombian populations.
Imprinted Genes PWCR1/Pwcr1 Encode Small RNA,
by de los Santos et al. (p. 1067)
The loss of paternal genes in the 15q11-q13 region leads
to the neurodevelopmental disorder Prader-Willi syn-
drome (PWS). Although several genes in this region have
been identified, mouse models for PWS suggest that an
unknown gene may be responsible, at least in part, for
the phenotype of this disorder. de los Santos et al. have
identified an additional gene in the 15q11-q13 region
and have named it “PWCR1.” To facilitate an experi-
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mental model for studies of this gene, the authors have
also gone on to find the mouse orthologue, dubbed
“Pwcr1.” PWCR1 is an intronless, noncoding gene that
is not expressed in cells from patients with PWS. A re-
gion of PWCR1 is conserved in mammals, and it has
similarity to the box C/D class of small nucleolar RNAs
(snoRNAs). These RNAs are components of ribonucle-
oproteins that assist in the processing of certain rRNA
transcripts and in RNA modification. The physiological
role for PWCR1, including the snoRNA-like domains,
is not yet clear, but the authors hypothesize that loss of
PWCR1 could lead to disrupted RNA modification,
which, in turn, could lead to the phenotype of PWS.
ML4, a Novel Gene Mutated in MLIV, by Bassi et al.
(p. 1110); and ALX4, a Candidate for Parietal
Foramina, by Wu et al. (p. 1327)
The work by Bassi et al. and Wu et al. demonstrates the
powers of bioinformatics and the human genome da-
tabases. Through use of these tools, each group has iden-
tified a gene that is associated with a particular genetic
disorder. Bassi et al. searched the region on chromosome
19p13.2-13.3 that had been identified, through linkage
mapping, as being associated with mucolipidosis type IV
(MLIV), a lysosomal storage disorder characterized by
corneal clouding and psychomotor retardation. Several
novel genes were identified in this search, and two mu-
tations in one of these genes, named “ML4” by the au-
thors, were identified in six patients with MLIV. Each
mutation was associated with one of the two disease-
associated haplotypes that have been reported previ-
ously, lending further support to their identification as
the causative mutations for this disease. The protein en-
coded by ML4, mucolipidin, is predicted to be an in-
tegral membrane protein, and it possesses a region of
homology to a putative Ca2 channel. Since cells from
patients with MLIV show alterations in the movement
of endocytic markers, further studies of ML4 may lead
not only to an elucidation of the basis for mucolipidosis
IV but also to a greater understanding of normal en-
docytic processes.
Wu et al. studied a contiguous deletion syndrome, of
chromosome 11, that includes parietal foramina as a
phenotype. Parietal foramina are defects in the parietal
bones of the skull that result from either delay or loss
of ossification. The authors hypothesized that a homo-
logue of the MSX2 gene, mutations in which cause au-
tosomal dominant parietal foramina, could also be re-
sponsible for the parietal foramina in this syndrome.
They performed a search for MSX2 homologues and
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found a clone that mapped to chromosome 11p. Two
patients with the contiguous deletion syndrome of chro-
mosome 11 had deletions of the genetic region corre-
sponding to this clone, indicating that this gene may
indeed play a role in the phenotype of this disorder. Since
this gene is expressed in bone but not in any of the other
tissues tested, and since it has homology to the mouse
homeobox gene Alx4, which is involved in skull devel-
opment, the authors suggest that deletions of the gene
may be responsible for the parietal foramina seen in this
syndrome. These papers by Wu et al. and Bassi et al.
provide excellent examples as to how genome databases
can be used to hasten human genetics research.
FOXC1 Duplication Causes Iris Hypoplasia, by
Lehmann et al. (p. 1129)
Mutations in the FOXC1 transcription factor gene have
been associated with glaucoma phenotypes. Some fam-
ilies that are affected by glaucoma, although they show
linkage to the 6p25 region where FOXC1 is located, do
not have mutations in FOXC1. In their article, Lehmann
et al. report that they have further genotyped one such
family and present some unusual results for the micro-
satellite marker D6S967, which is located in the 6p25
region. As is seen in a PCR assay, affected individuals
in this family possess either three alleles for D6S967 or
two alleles for D6S967; in the latter case, one of the two
alleles has twice the normal band intensity. FISH con-
firmed a statistically significant increase in the propor-
tion of asymmetrical signals for the 6p25 probe in cells
from the affected patients compared with controls. These
results suggest that the glaucoma and iris hypoplasia
phenotypes in this family result from a duplication of
the genetic region containing FOXC1. Since FOXC1 is
thought to be a transcription factor, the authors hy-
pothesize that a change in FOXC1 gene dosage leads to
an altered pattern of downstream gene expression.
Cloning of a Fanconi Anemia Gene, by de Winter et
al. (p. 1306)
Through complementation of a phenotype, Johan de
Winter et al. have been able to clone a cDNA for the
Fanconi anemia (FA) complementation group E. FA is
a chromosomal instability syndrome characterized by a
wide range of developmental disorders, bone marrow
failure, and predisposition to malignancies. Cells from
these patients exhibit hypersensitivity to mitomycin C
and other DNA cross-linking agents. The authors have
made use of this phenotype in a selection scheme. An
FA group E cell line was transfected with an expres-
sion library and put under selection with mitomycin C.
The cDNA isolated in this scheme was used to identify
the corresponding human genomic sequence, termed
“FANCE.” As is the case for the other FA proteins iden-
tified to date, FANCE lacks any significant homology to
other proteins. FA has been a very puzzling disorder
because none of the causative genes has given an im-
mediate clue as to the underlying pathway that is dis-
rupted in this disorder. The recent discovery that FANCC
is involved in STAT1 activation (see Pang et al.’s article
in Molecular and Cellular Biology [20:4724–4735;
2000]) may help to unravel the underlying mechanism
for FA. Additional studies will further delineate the de-
velopmentally critical biochemical pathway involved in
this disorder.
KATHRYN BEAUREGARD
Editorial Fellow
